VEGF-B Antibodies

Santa Cruz Biotechnology delivers a wide array of VEGF-B monoclonal antibodies for various research applications. VEGF-B Antibodies are validated for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Vascular Endothelial Growth Factor B (VEGF-B) plays a crucial role in angiogenesis and the maintenance of vascular integrity. VEGF-B is involved in the regulation of blood vessel formation and has been implicated in various pathological conditions, including cancer and cardiovascular diseases. Understanding VEGF-B function is essential for developing therapeutic strategies targeting these conditions. VEGF-B research continues to reveal new insights into vascular development and disease progression. Ongoing studies of VEGF-B signaling pathways contribute to our understanding of blood vessel growth and maintenance. VEGF-B investigation has opened new avenues for potential therapeutic interventions in vascular disorders. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing VEGF-B research and developing innovative therapeutic approaches.